Monday, June 15, 2020

Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Only 13 % know: The one-minute self-exam that could save young men’s lives

A new survey shows most Americans wrongly think testicular cancer is an older man's issue, despite it most commonly affecting men aged 2...